Literature DB >> 16354642

A case of primary adenocarcinoma of the lacrimal sac.

Paul A Brannan1, Robert C Kersten, Susan Schneider, Dwight R Kulwin.   

Abstract

PURPOSE: To present a rare case of adenocarcinoma arising from the lacrimal sac.
DESIGN: Interventional case report.
METHODS: Report of a new case of primary lacrimal sac adenocarcinoma.
RESULTS: The clinical presentation, workup, surgical treatment and pathology of a case of adenocarcinoma of the lacrimal sac are described.
CONCLUSION: Although very rare, these tumors should be in the differential diagnosis of any lacrimal sac mass, especially those presenting above the medial canthal tendon. Other common features include expressible blood from the punctum, lack of pain, and a history of chronic epiphora or intermittent dacryocystitis. Local destruction and metastatic spread can be prevented by a high index of suspicion and early intervention.

Entities:  

Mesh:

Year:  2005        PMID: 16354642     DOI: 10.1080/01676830500182739

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  6 in total

1.  A case of primary oncocytic adenocarcinoma of the lacrimal sac.

Authors:  Jingxue Zhang; Ningli Wang; Jitong Shi; Xin Ge
Journal:  BMJ Case Rep       Date:  2009-07-12

2.  Lacrimal Sac Tumors: A Case Series.

Authors:  Syeed Mehbub Ul Kadir; Riffat Rashid; Sadia Sultana; Murtuza Nuruddin; Mst Sayedatun Nessa; Mukti Rani Mitra; Golam Haider
Journal:  Ocul Oncol Pathol       Date:  2021-10-18

Review 3.  Primary ductal adenocarcinoma of the lacrimal sac: the first reported case.

Authors:  Mitsuaki Ishida; Muneo Iwai; Keiko Yoshida; Akiko Kagotani; Hideaki Kohzaki; Masahiko Arikata; Takeshi Shimizu; Hidetoshi Okabe
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

4.  Salivary duct carcinoma in the sinonasal tract.

Authors:  Ryuzaburo Higo; Toshihiko Takahashi; Hiroto Nakata; Hiroshi Harada; Masashi Sugasawa
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-01-03       Impact factor: 3.236

5.  Androgen-Receptor Positive Lacrimal Sac Adenocarcinoma Demonstrating Long-Lasting Response to LHRH Analog Plus Abiraterone Treatment.

Authors:  Elena Vagia; Panagiota Economopoulou; Nikolaos Oikonomopoulos; Ilias Athanasiadis; George Dimitriadis; Amanda Psyrri
Journal:  Front Oncol       Date:  2015-02-02       Impact factor: 6.244

6.  Lacrimal sac adenocarcinoma managed with androgen deprivation.

Authors:  David H Abramson; Julia Fallon; Noa Biran; Jasmine H Francis; Korey Jaben; William K Oh
Journal:  Am J Ophthalmol Case Rep       Date:  2020-07-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.